Sesen Bio, Inc. (SESN) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 35 transactions totaling $842.9K, demonstrating a bearish sentiment with -$842.9K in net insider flow. The most recent transaction on Mar 2, 2023 involved a sale of 98,304 shares valued at $58.0K.
No significant insider buying has been recorded for SESN in the recent period.
No significant insider selling has been recorded for SESN in the recent period.
Based on recent SEC filings, insider sentiment for SESN is bearish with an Insider Alignment Score of 0/100 and a net flow of -$842.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Sesen Bio, Inc. (SESN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading SESN stock, having executed 35 transactions in the past 90 days. The most active insider is Thomas R. Cannell (Executive), who has made 5 transactions totaling $677.3K.
Get notified when executives and directors at SESN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Forbes Monica | Executive | Sale | 98,304 | $0.59 | $58.0K | |
| Mar 2, 2023 | Forbes Monica | Executive | Option Exercise | 180,750 | $0.59 | $106.6K | |
| Mar 2, 2023 | Forbes Monica | Executive | Sale | 93,279 | $0.59 | $55.0K | |
| Mar 2, 2023 | Forbes Monica | Executive | Option Exercise | 190,375 | $0.59 | $112.3K | |
| Mar 2, 2023 | Forbes Monica | Executive | Sale | 154,266 | $0.59 | $91.0K | |
| Mar 2, 2023 | R. Cannell Thomas | Executive | Sale | 278,564 | $0.59 | $164.4K | |
| Mar 2, 2023 | R. Cannell Thomas | Executive | Sale | 208,923 | $0.59 | $123.3K | |
| Mar 2, 2023 | R. Cannell Thomas | Executive | Option Exercise | 606,800 | $0.59 | $358.0K | |
| Mar 2, 2023 | Ryu Elly | Executive | Sale | 17,289 | $0.59 | $10.2K | |
| Mar 2, 2023 | C. Macdonald Glen | Executive | Option Exercise | 183,317 | $0.59 | $108.2K | |
| Mar 2, 2023 | C. Macdonald Glen | Executive | Sale | 33,888 | $0.59 | $20.0K | |
| Mar 2, 2023 | C. Macdonald Glen | Executive | Sale | 60,237 | $0.59 | $35.5K | |
| Mar 2, 2023 | C. Macdonald Glen | Executive | Option Exercise | 102,975 | $0.59 | $60.8K | |
| Mar 2, 2023 | C. Macdonald Glen | Executive | Sale | 76,247 | $0.59 | $45.0K | |
| Mar 2, 2023 | Sullivan Mark | Executive | Sale | 73,361 | $0.59 | $43.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 7 | $921.8K | 52.2% |
Sale(S) | 17 | $842.9K | 47.8% |
Award(A) | 11 | $0 | 0.0% |
Insider selling pressure at Sesen Bio, Inc. has increased, with 10 insiders executing 35 transactions across all time. Total sales of $842.9K significantly outpace purchases of $0, resulting in a net outflow of $842.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.